Top

High Blood Pressure & Cardiovascular Prevention

Published in:

01-07-2008 | Contributions from International Congress

9.5 Impact of Antihypertensive Treatment on Long-Term Risk of Diabetes Mellitus in a General Population Setting: Data from the PAMELA Study

Authors: M. Bombelli, M. Rondinelli, R. Sanvito, D. Fodri, E. Toso, H. Polo Friz, A. Casati, L. Primitz, F. Ganz, S. Buzzi, F. Quarti-Trevano, G. Grassi, R. Sega, G. Mancia

Published in: High Blood Pressure & Cardiovascular Prevention | Issue 3/2008

Excerpt

Introduction. In several controlled clinical trials, some types of antihypertensive treatment were found to be associated to some metabolic adverse effects, among which an enhanced number of cases of diabetes mellitus (DM). Fewer data, however, are available on this issue in the setting of the general population. …

Title: 9.5 Impact of Antihypertensive Treatment on Long-Term Risk of Diabetes Mellitus in a General Population Setting: Data from the PAMELA Study
Authors: M. Bombelli
M. Rondinelli
R. Sanvito
D. Fodri
E. Toso
H. Polo Friz
A. Casati
L. Primitz
F. Ganz
S. Buzzi
F. Quarti-Trevano
G. Grassi
R. Sega
G. Mancia
Publication date: 01-07-2008
Publisher: Springer International Publishing
Published in: High Blood Pressure & Cardiovascular Prevention / Issue 3/2008
Print ISSN: 1120-9879
Electronic ISSN: 1179-1985
DOI: https://doi.org/10.1007/BF03263677

Keynote webinar | Spotlight on medication adherence

Springer Medicine

9.5 Impact of Antihypertensive Treatment on Long-Term Risk of Diabetes Mellitus in a General Population Setting: Data from the PAMELA Study

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2008

1.2 Comparison Between CRP and Other Conventional Risk Factors on Arterial Stiffness in Treated Essential Hypertension

11.6 Determinants of Resistant Hypertension in a Sample of Adult Male Population (8-Year Follow-Up)

6.9 Plasma Aldosterone and Albumin Urinary Excretion in Hypertension

11.9 Differences between ACE Inhibitor and Angiotensin II Receptor Blocker-based therapy in preventing myocardial infarction, stroke and cardiovascular mortality: a meta-analysis

2.4 White Coat and Masked Hypertension Increase the Risk of New Onset Sustained Hypertension in the General Population

Is C-Reactive Protein a Reliable Risk Factor of Cardiovascular Morbidity and Mortality in Clinical Practice?